Short Interest in Biofrontera Inc. (NASDAQ:BFRI) Declines By 22.7%

Biofrontera Inc. (NASDAQ:BFRI) was the target of a large drop in short interest in December. As of December 15th, there was short interest totalling 530,600 shares, a drop of 22.7% from the November 30th total of 686,600 shares. Currently, 8.5% of the company’s stock are sold short. Based on an average daily trading volume, of 2,870,000 shares, the short-interest ratio is presently 0.2 days.

Analysts Set New Price Targets

Separately, Benchmark reiterated a “buy” rating and set a $7.00 price objective on shares of Biofrontera in a research note on Friday, November 15th.

Biofrontera Trading Up 3.7 %

Shares of BFRI traded up $0.04 during midday trading on Friday, hitting $1.11. 218,657 shares of the company’s stock traded hands, compared to its average volume of 1,018,731. Biofrontera has a 1 year low of $0.61 and a 1 year high of $3.90. The firm’s fifty day moving average is $0.96 and its 200-day moving average is $1.04. The stock has a market capitalization of $8.60 million, a price-to-earnings ratio of -0.49 and a beta of 0.38.

Biofrontera Company Profile

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.